Denemek ALTIN - Özgür
JK Cement stock's flawless run
Mint Chennai
|September 04, 2025
Scaling without stretching
JK Cement Ltd's shares have rallied as much as 47% so far in 2025 on strong project execution, healthy earnings, and a clear growth roadmap.
In this backdrop, some brokerages have raised their valuation multiples. For instance, ICICI Securities Ltd now values JK Cement at 22X FY27 estimated EV/Ebitda (18X earlier), tracking its great project execution capabilities and its crowning achievement of the past 10 years' Ebitda per tonne being the most pronounced of cement majors.
"ROE (return on equity) too has transcended peers all along," said ICICI on 1 September. The brokerage reckons JK Cement's valuation multiple may converge to being at par with peers once growth matures.
JM Financial Institutional Securities raised its target multiple by a notch to 18.5X, with strong earnings visibility (>20% Ebitda CAGR), controlled leverage, and improving return ratios.
Bu hikaye Mint Chennai dergisinin September 04, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Chennai'den DAHA FAZLA HİKAYE
Mint Chennai
Adani shares slide up to 15% after SEC moves court to serve direct summons
FROM PAGE 16
2 mins
January 24, 2026
Mint Chennai
Adani Group shares fall up to 15% after US SEC move
News of the US market regulator seeking to send summons in a bribery case directly to Adani Group promoter Gautam Adani and his nephew Sagar sent the group’s listed stocks tumbling between 3% and 15% on Friday.
1 min
January 24, 2026
Mint Chennai
WhiteSpace Consulting & Capability Building: Healthcare consulting that delivers
In healthcare and life sciences, ideas are abundant.
1 min
January 24, 2026
Mint Chennai
The city beside the layer of concrete
A sound cuts through the quiet, hibernating winter air.
5 mins
January 24, 2026
Mint Chennai
Dr Madhuresh K Sethi: Patent defender
In the unforgiving arena of pharmaceutical patent litigation, few names command as much respect as Dr Madhuresh Kumar Sethi.
1 mins
January 24, 2026
Mint Chennai
Budget may update MSME debt framework to provide relief
The development assumes significance given that India's 7.4 million MSMEs contribute about 45% to its exports, about 30% of India’s total economic output and employ 330 million people.
2 mins
January 24, 2026
Mint Chennai
Coforge, Mphasis defy seasonality, beat Street view
Defying seasonal weaknesses, mid-sized information technology (IT) outsourcers Coforge Ltd and Mphasis Ltd beat analyst expectations for the October-December 2025 quarter, mirroring the trend of their mid-sized peers.
1 mins
January 24, 2026
Mint Chennai
Top steel cos face CCI pricing probe
Four major steelmakers— Tata Steel, JSW Steel and state-run SAIL and RINL —disclosed their pricing plans to rivals and coordinated production cuts to reduce supplies, an antitrust investigation report seen by Reuters shows.
1 min
January 24, 2026
Mint Chennai
Inside Cosmo First's move beyond packaging
In 1981, when India’s packaging industry was primitive, technical expertise scarce, and global competitors formidable, Ashok Jaipuria saw what others missed.
1 mins
January 24, 2026
Mint Chennai
Leading the Green Revolution: Debabrata Sarkar’s journey
Debabrata Sarkar is a highly accomplished C-level executive and TEDx speaker with over 26 years of experience in the international agriculture sector.
1 mins
January 24, 2026
Listen
Translate
Change font size

